help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strowski, M. Z.
Right arrow Articles by Schaeffer, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strowski, M. Z.
Right arrow Articles by Schaeffer, J. M.
Endocrinology Vol. 141, No. 1 111-117
Copyright © 2000 by The Endocrine Society

ARTICLES

Somatostatin Inhibits Insulin and Glucagon Secretion via Two Receptor Subtypes: An in Vitro Study of Pancreatic Islets from Somatostatin Receptor 2 Knockout Mice1

M. Z. Strowski, R. M. Parmar, A. D. Blake and J. M. Schaeffer

Department of Endocrinology and Chemical Biology, Merck Research Laboratories, Rahway, New Jersey 07065

Address all correspondence and requests for reprints to: Dr. Mathias Strowski, Merck Research Laboratories, Department of Endocrinology and Chemical Biology, RY80T-126, P.O. Box 2000, Rahway, New Jersey 07065. E-mail: mathias_strowski{at}merck.com

Somatostatin (SST) potently inhibits insulin and glucagon release from pancreatic islets. Five distinct membrane receptors (SSTR1–5) for SST are known, and at least two (SSTR2 and SSTR5) have been proposed to regulate pancreatic endocrine function. Our current understanding of SST physiology is limited by the receptor subtype selectivity of peptidyl SST analogs, making it difficult to assign a physiological function to an identified SST receptor subtype. To better understand the physiology of SSTRs we studied the in vitro effects of potent subtype-selective nonpeptidyl SST analogs on the regulation of pancreatic glucagon and insulin secretion in wild-type (WT) and in somatostatin receptor 2 knockout (SSTR2KO) mice.

There was no difference in basal glucagon and insulin secretion between islets isolated from SSTR2KO and WT mice; however, potassium/arginine-stimulated glucagon secretion was approximately 2-fold higher in islets isolated from SSTR2KO mice. Neither SST nor any SSTR-selective agonist inhibited basal glucagon or insulin release. SST-14 potently inhibited stimulated glucagon secretion in islets from WT mice and much less effectively in islets from SSTR2KO mice. The SSTR2 selective analog L-779,976 inhibited glucagon secretion in islets from WT, but was inactive in islets from SSTR2KO mice. L-817,818, an SSTR5 selective analog, slightly reduced glucagon release in both animal groups, whereas SSTR1, -3, and -4 selective analogs were inactive. SST and L-817,818 inhibited glucose stimulated insulin release in islets from WT and SSTR2KO mice. L-779,976 much less potently reduced insulin secretion from WT islets.

In conclusion, our data demonstrate that SST inhibition of glucagon release in mouse islets is primarily mediated via SSTR2, whereas insulin secretion is regulated primarily via SSTR5.




This article has been cited by other articles:


Home page
 EndocrinologyHome page
R. M. Luque and R. D. Kineman
Gender-Dependent Role of Endogenous Somatostatin in Regulating Growth Hormone-Axis Function in Mice
Endocrinology, December 1, 2007; 148(12): 5998 - 6006.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
V. Singh, C. Grotzinger, K. W. Nowak, S. Zacharias, E. Goncz, G. Pless, I. M. Sauer, I. Eichhorn, B. Pfeiffer-Guglielmi, B. Hamprecht, et al.
Somatostatin Receptor Subtype-2-Deficient Mice with Diet-Induced Obesity Have Hyperglycemia, Nonfasting Hyperglucagonemia, and Decreased Hepatic Glycogen Deposition
Endocrinology, August 1, 2007; 148(8): 3887 - 3899.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S.-K. Yang, H. C. Parkington, J. Epelbaum, D. J. Keating, and C. Chen
Somatostatin decreases voltage-gated Ca2+ currents in GH3 cells through activation of somatostatin receptor 2
Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1863 - E1870.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. Gromada, I. Franklin, and C. B. Wollheim
{alpha}-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains
Endocr. Rev., February 1, 2007; 28(1): 84 - 116.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
V. Singh, M. D. Brendel, S. Zacharias, S. Mergler, H. Jahr, B. Wiedenmann, R. G. Bretzel, U. Plockinger, and M. Z. Strowski
Characterization of Somatostatin Receptor Subtype-Specific Regulation of Insulin and Glucagon Secretion: An in Vitro Study on Isolated Human Pancreatic Islets
J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 673 - 680.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. de Heer and J. J. Holst
Sulfonylurea Compounds Uncouple the Glucose Dependence of the Insulinotropic Effect of Glucagon-Like Peptide 1
Diabetes, February 1, 2007; 56(2): 438 - 443.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Z. Strowski, D. E. Cashen, E. T. Birzin, L. Yang, V. Singh, T. M. Jacks, K. W. Nowak, S. P. Rohrer, A. A. Patchett, R. G. Smith, et al.
Antidiabetic Activity of a Highly Potent and Selective Nonpeptide Somatostatin Receptor Subtype-2 Agonist
Endocrinology, October 1, 2006; 147(10): 4664 - 4673.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. Cheyssac, C. Dina, F. Lepretre, V. Vasseur-Delannoy, A. Dechaume, S. Lobbens, B. Balkau, J. Ruiz, G. Charpentier, F. Pattou, et al.
EIF4A2 Is a Positional Candidate Gene at the 3q27 Locus Linked to Type 2 Diabetes in French Families.
Diabetes, April 1, 2006; 55(4): 1171 - 1176.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
W. Wente, T. Stroh, A. Beaudet, D. Richter, and H.-J. Kreienkamp
Interactions with PDZ Domain Proteins PIST/GOPC and PDZK1 Regulate Intracellular Sorting of the Somatostatin Receptor Subtype 5
J. Biol. Chem., September 16, 2005; 280(37): 32419 - 32425.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
E Ludvigsen, M Stridsberg, E T Janson, and S Sandler
Expression of somatostatin receptor subtypes 1-5 in pancreatic islets of normoglycaemic and diabetic NOD mice
Eur. J. Endocrinol., September 1, 2005; 153(3): 445 - 454.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
P. Collombat, J. Hecksher-Sorensen, V. Broccoli, J. Krull, I. Ponte, T. Mundiger, J. Smith, P. Gruss, P. Serup, and A. Mansouri
The simultaneous loss of Arx and Pax4 genes promotes a somatostatin-producing cell fate specification at the expense of the {alpha}- and {beta}-cell lineages in the mouse endocrine pancreas
Development, July 1, 2005; 132(13): 2969 - 2980.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
Y. Segev, R. Eshet, I. Rivkis, C. Hayat, L. Kachko, M. Phillip, and D. Landau
Comparison between somatostatin analogues and ACE inhibitor in the NOD mouse model of diabetic kidney disease
Nephrol. Dial. Transplant., December 1, 2004; 19(12): 3021 - 3028.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
Genetically Modified Animals in Endocrinology
Endocr. Rev., August 1, 2004; 25(4): 673 - 677.
[Full Text] [PDF]

Home page
 DiabetesHome page
A. Muroyama, S. Uehara, S. Yatsushiro, N. Echigo, R. Morimoto, M. Morita, M. Hayashi, A. Yamamoto, D.-S. Koh, and Y. Moriyama
A Novel Variant of Ionotropic Glutamate Receptor Regulates Somatostatin Secretion From {delta}-Cells of Islets of Langerhans
Diabetes, July 1, 2004; 53(7): 1743 - 1753.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
E. Ludvigsen, R. Olsson, M. Stridsberg, E. T. Janson, and S. Sandler
Expression and Distribution of Somatostatin Receptor Subtypes in the Pancreatic Islets of Mice and Rats
J. Histochem. Cytochem., March 1, 2004; 52(3): 391 - 400.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. van der Hoek, W. W. de Herder, R. A. Feelders, A.-J. van der Lely, P. Uitterlinden, V. Boerlin, C. Bruns, K. W. Poon, I. Lewis, G. Weckbecker, et al.
A Single-Dose Comparison of the Acute Effects between the New Somatostatin Analog SOM230 and Octreotide in Acromegalic Patients
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 638 - 645.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. Bertherat, F. Tenenbaum, K. Perlemoine, C. Videau, J. L. Alberini, B. Richard, B. Dousset, X. Bertagna, and J. Epelbaum
Somatostatin Receptors 2 and 5 Are the Major Somatostatin Receptors in Insulinomas: An in Vivo and in Vitro Study
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5353 - 5360.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
K. Cejvan, D. H. Coy, and S. Efendic
Intra-Islet Somatostatin Regulates Glucagon Release via Type 2 Somatostatin Receptors in Rats
Diabetes, May 1, 2003; 52(5): 1176 - 1181.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
A.-Y. Gong, P. S. Tietz, M. A. Muff, P. L. Splinter, R. C. Huebert, M. Z. Strowski, X.-M. Chen, and N. F. LaRusso
Somatostatin stimulates ductal bile absorption and inhibits ductal bile secretion in mice via SSTR2 on cholangiocytes
Am J Physiol Cell Physiol, May 1, 2003; 284(5): C1205 - C1214.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
M. Z. Strowski, M. Kohler, H. Y. Chen, M. E. Trumbauer, Z. Li, D. Szalkowski, S. Gopal-Truter, J. K. Fisher, J. M. Schaeffer, A. D. Blake, et al.
Somatostatin Receptor Subtype 5 Regulates Insulin Secretion and Glucose Homeostasis
Mol. Endocrinol., January 1, 2003; 17(1): 93 - 106.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
K. Cejvan, D. H. Coy, J. J. Holst, E. Cerasi, and S. Efendic
Gliclazide Directly Inhibits Arginine-Induced Glucagon Release
Diabetes, December 1, 2002; 51(90003): S381 - 384.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. Chisholm and G. R. Greenberg
Somatostatin-28 regulates GLP-1 secretion via somatostatin receptor subtype 5 in rat intestinal cultures
Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E311 - E317.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
G. Tulipano, D. Soldi, M. Bagnasco, M. D. Culler, J. E. Taylor, D. Cocchi, and A. Giustina
Characterization of New Selective Somatostatin Receptor Subtype-2 (sst2) Antagonists, BIM-23627 and BIM-23454. Effects of BIM-23627 on GH Release in Anesthetized Male Rats after Short-Term High-Dose Dexamethasone Treatment
Endocrinology, April 1, 2002; 143(4): 1218 - 1224.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Ballare, L. Persani, A. G. Lania, M. Filopanti, E. Giammona, S. Corbetta, S. Mantovani, M. Arosio, P. Beck-Peccoz, G. Faglia, et al.
Mutation of Somatostatin Receptor Type 5 in an Acromegalic Patient Resistant to Somatostatin Analog Treatment
J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3809 - 3814.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Afargan, E. T. Janson, G. Gelerman, R. Rosenfeld, O. Ziv, O. Karpov, A. Wolf, M. Bracha, D. Shohat, G. Liapakis, et al.
Novel Long-Acting Somatostatin Analog with Endocrine Selectivity: Potent Suppression of Growth Hormone But Not of Insulin
Endocrinology, January 1, 2001; 142(1): 477 - 486.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
C. Chisholm and G. R. Greenberg
Somatostatin receptor subtype-5 mediates inhibition of peptide YY secretion from rat intestinal cultures
Am J Physiol Gastrointest Liver Physiol, November 1, 2000; 279(5): G983 - G989.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society